Australia Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
Summary
Generics in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Australian generics market had total revenues of $1.4bn in 2021, representing a compound annual growth rate (CAGR) of 3.7% between 2016 and 2021.
- Market consumption volume increased with a CAGR of 4.9% between 2016 and 2021, to reach a total of 70.1 % in 2021.
- Growth in the market has been driven by demographic trends, primarily the general aging of the population which has increased the market for generics.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Australia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Australia
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Australia generics market with five year forecasts
- What was the size of the Australia generics market by value in 2021?
- What will be the size of the Australia generics market in 2026?
- What factors are affecting the strength of competition in the Australia generics market?
- How has the market performed over the last five years?
- What are the main segments that make up Australia's generics market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Market volume
- 1.4. Market volume forecast
- 1.5. Geography segmentation
- 1.6. Market rivalry
- 1.7. Competitive Landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 3.2. Market volume
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 5.2. Market volume forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What are the strengths/weaknesses of the leading players?
- 7.3. Has there been any significant recent M&A activity?
- 7.4. How did the COVID-19 pandemic impact leading players?
- 8 Company Profiles
- 8.1. Teva Pharmaceutical Industries Limited
- 8.2. Viatris Inc.
- 8.3. Aspen Pharmacare Holdings Ltd
- 8.4. Lupin Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. About MarketLine
- List of Tables
- Table 1: Australia generics market value: $ million, 2016-21
- Table 2: Australia generics market volume: %, 2016-21
- Table 3: Australia generics market geography segmentation: $ million, 2021
- Table 4: Australia generics market value forecast: $ million, 2021-26
- Table 5: Australia generics market volume forecast: %, 2021-26
- Table 6: Teva Pharmaceutical Industries Limited: key facts
- Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
- Table 8: Teva Pharmaceutical Industries Limited: Key Employees
- Table 9: Viatris Inc.: key facts
- Table 10: Viatris Inc.: Annual Financial Ratios
- Table 11: Viatris Inc.: Key Employees
- Table 12: Viatris Inc.: Key Employees Continued
- Table 13: Aspen Pharmacare Holdings Ltd: key facts
- Table 14: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
- Table 15: Aspen Pharmacare Holdings Ltd: Key Employees
- Table 16: Lupin Ltd: key facts
- Table 17: Lupin Ltd: Annual Financial Ratios
- Table 18: Lupin Ltd: Key Employees
- Table 19: Lupin Ltd: Key Employees Continued
- Table 20: Australia size of population (million), 2017-21
- Table 21: Australia gdp (constant 2005 prices, $ billion), 2017-21
- Table 22: Australia gdp (current prices, $ billion), 2017-21
- Table 23: Australia inflation, 2017-21
- Table 24: Australia consumer price index (absolute), 2017-21
- Table 25: Australia exchange rate, 2017-21
- List of Figures
- Figure 1: Australia generics market value: $ million, 2016-21
- Figure 2: Australia generics market volume: %, 2016-21
- Figure 3: Australia generics market geography segmentation: % share, by value, 2021
- Figure 4: Australia generics market value forecast: $ million, 2021-26
- Figure 5: Australia generics market volume forecast: %, 2021-26
- Figure 6: Forces driving competition in the generics market in Australia, 2021
- Figure 7: Drivers of buyer power in the generics market in Australia, 2021
- Figure 8: Drivers of supplier power in the generics market in Australia, 2021
- Figure 9: Factors influencing the likelihood of new entrants in the generics market in Australia, 2021
- Figure 10: Factors influencing the threat of substitutes in the generics market in Australia, 2021
- Figure 11: Drivers of degree of rivalry in the generics market in Australia, 2021
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook